NM_004752.4(GCM2):c.1181A>C (p.Tyr394Ser) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 14, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001861265.6

Allele description [Variation Report for NM_004752.4(GCM2):c.1181A>C (p.Tyr394Ser)]

NM_004752.4(GCM2):c.1181A>C (p.Tyr394Ser)

Gene:
GCM2:glial cells missing transcription factor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p24.2
Genomic location:
Preferred name:
NM_004752.4(GCM2):c.1181A>C (p.Tyr394Ser)
HGVS:
  • NC_000006.12:g.10874335T>G
  • NG_008970.1:g.12531A>C
  • NM_004752.4:c.1181A>CMANE SELECT
  • NP_004743.1:p.Tyr394Ser
  • NP_004743.1:p.Tyr394Ser
  • NC_000006.11:g.10874568T>G
  • NM_004752.3:c.1181A>C
Protein change:
Y394S; TYR394SER
Links:
OMIM: 603716.0005; dbSNP: rs142287570
NCBI 1000 Genomes Browser:
rs142287570
Molecular consequence:
  • NM_004752.4:c.1181A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002176607Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 14, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.

Riccardi A, Aspir T, Shen L, Kuo CL, Brown TC, Korah R, Murtha TD, Bellizzi J, Parham K, Carling T, Costa-Guda J, Arnold A.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):1948-1952. doi: 10.1210/jc.2018-02517.

PubMed [citation]
PMID:
30624640

Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism.

Guan B, Welch JM, Vemulapalli M, Li Y, Ling H, Kebebew E, Simonds WF, Marx SJ, Agarwal SK.

J Endocr Soc. 2017 May 1;1(5):488-499. doi: 10.1210/js.2017-00043.

PubMed [citation]
PMID:
29264504
PMCID:
PMC5686704
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002176607.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 394 of the GCM2 protein (p.Tyr394Ser). This variant is present in population databases (rs142287570, gnomAD 1.3%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with hyperparathyroidism and/or parathyroid adenomas (PMID: 29264504, 30624640, 35038313). It is commonly reported in individuals of Ashkenazi Jewish ancestry (PMID: 29264504). ClinVar contains an entry for this variant (Variation ID: 355008). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GCM2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects GCM2 function (PMID: 29264504, 35038313). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024